Thrombin inhibitors have been designed with the replacement of the strongly
basic guanidine P1 pharmocophore with a group that exploits the lipophilic
ty of the S1 pocket. The approach has lead to the discovery of potent throm
bin inhibitors demonstrating good intra-duodenal absorption. (C) 1999 Elsev
ier Science Ltd. All rights reserved.